![John M. Sorvillo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John M. Sorvillo
Nessuna posizione attualmente
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Patrick Zenner | M | 77 | - | |
Stephen Hill | M | 65 | 9 anni | |
Georges Gemayel | M | 63 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 1 anni |
Thomas J. Phair | M | - |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 3 anni |
Sheldon Berkle | M | 78 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 3 anni |
Jonathan Lieber | M | 54 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 7 anni |
Anthony S. Messina | M | - | - | |
David Hastings | M | 62 | 3 anni | |
David D. Pendergast | M | 76 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | - |
Bruce A. Leicher | M | 68 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 2 anni |
Burkhard Blank | M | 69 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 3 anni |
Manish Tandon | M | - | - | |
Bruce Ganem | M | - | 4 anni | |
Louise A. Mawhinney | F | 68 | 3 anni | |
Robert Gallotto | M | 59 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 7 anni |
Andrew C. G. Uprichard | M | 66 | 1 anni | |
Kenneth Attie | M | 67 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 2 anni |
Alexey L. Margolin | M | 71 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 14 anni |
Lauren Sabella | F | 63 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 2 anni |
John P. Richard | M | 66 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 8 anni |
Chiang J. Li | M | 59 | 4 anni | |
James N. Kyranos | M | - | - | |
John Celebi | M | 52 | 8 anni | |
J. David Jacobs | M | - | 3 anni | |
Timothy Barabe | M | 71 | 19 anni | |
Philip Gotwals | M | 61 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 3 anni |
Renato Fuchs | M | 80 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 1 anni |
Stewart John Hen | M | 57 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 4 anni |
Jonathan Leff | M | 55 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 4 anni |
Tuan Ha-Ngoc | M | 72 | 4 anni | |
Werner Cautreels | M | 71 | 7 anni | |
John Gustofson | M | - |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 4 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 32 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- John M. Sorvillo
- Contatti personali